Keystone Biologics receives $244,000 grant from the Qualified Therapeutic Discovery Project

The Qualified Therapeutic Discovery Project (QTDP) program is part of the Patient Protection and Affordable Care Act of 2010 and provides a 50% tax credit or grant to biotech, pharmaceutical and other healthcare companies for qualified investments. Keystone Biologics was selected from the more than 7000 companies that applied for the grants.